Sandra I. Bril

Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer

Anne W. Wendrich, Justin E. Swartz, Sandra I. Bril et al. · Oral Oncology · 2017 · 225 citations

Chemotherapy Dose-limiting Toxicity, Neck Cancer, Predictive Factor +10

Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer

Najiba Chargi, Sandra I. Bril, Mariëlle H. Emmelot‐Vonk et al. · European Archives of Oto-Rhino-Laryngology · 2019 · 139 citations · Full text

Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy

Sandra I. Bril, Thomas F. Pézier, Bernard M. Tijink et al. · Head & Neck · 2019 · 87 citations · Full text

Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra

Sandra I. Bril, Anne W. Wendrich, Justin E. Swartz et al. · European Archives of Oto-Rhino-Laryngology · 2019 · 62 citations · Full text

Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma

Najiba Chargi, Sandra I. Bril, Justin E. Swartz et al. · Oral Oncology · 2019 · 44 citations · Full text